Plasmapheresis for Thrombotic Microangiopathy Due to a Post-transplant Lymphoproliferative Disorder

dc.contributor.authorYu Q.
dc.contributor.authorSuknuntha K.
dc.contributor.authorZhong W.
dc.contributor.authorMatson D.R.
dc.contributor.authorHess A.S.
dc.contributor.authorRose W.N.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:40:48Z
dc.date.available2023-06-18T17:40:48Z
dc.date.issued2022-11-01
dc.description.abstractWe report a case of thrombotic microangiopathy (TMA) diagnosed in the kidney allograft of a 59-year-old woman who had developed plasmacytoma type monomorphic posttransplant lymphoproliferative disorder (PTLD) 30 years after a simultaneous pancreas and kidney transplant. This report demonstrates a rare etiology of TMA in a kidney allograft occurring in association with PTLD-associated monoclonal gammopathy. The main teaching points are: 1) PTLD may be considered in the work-up of a new TMA in the immunosuppressed post-transplant setting, and 2) a paraprotein-associated condition should be considered as clinically relevant coexistent in a patient with TMA because paraproteins are over-represented in patients with otherwise unexplained TMAs.
dc.identifier.citationOBM Transplantation Vol.6 No.2 (2022)
dc.identifier.doi10.21926/obm.transplant.2202160
dc.identifier.eissn25775820
dc.identifier.scopus2-s2.0-85144101790
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/85383
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titlePlasmapheresis for Thrombotic Microangiopathy Due to a Post-transplant Lymphoproliferative Disorder
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85144101790&origin=inward
oaire.citation.issue2
oaire.citation.titleOBM Transplantation
oaire.citation.volume6
oairecerif.author.affiliationUniversity of Wisconsin School of Medicine and Public Health
oairecerif.author.affiliationFaculty of Medicine Ramathibodi Hospital, Mahidol University

Files

Collections